EI

EAM Investors Portfolio holdings

AUM $898M
1-Year Est. Return 288.34%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$898M
AUM Growth
+$25.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
377
New
Increased
Reduced
Closed

Top Buys

1
+$7.06M
2
+$5.57M
3
+$5.47M
4
TARS icon
Tarsus Pharmaceuticals
TARS
+$5.44M
5
BKD icon
Brookdale Senior Living
BKD
+$5.42M

Top Sells

1
+$8.08M
2
+$7.93M
3
+$7.75M
4
LIF
Life360
LIF
+$7.72M
5
CDTX
Cidara Therapeutics
CDTX
+$7.47M

Sector Composition

1 Healthcare 29.73%
2 Technology 20.64%
3 Industrials 18.62%
4 Financials 7.6%
5 Consumer Discretionary 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SENEA icon
226
Seneca Foods Class A
SENEA
$949M
$810K 0.09%
7,325
+462
MRAM icon
227
Everspin Technologies
MRAM
$200M
$803K 0.09%
+86,512
EGAN icon
228
eGain
EGAN
$262M
$802K 0.09%
77,970
KRMD icon
229
KORU Medical Systems
KRMD
$211M
$794K 0.09%
+136,716
AP icon
230
Ampco-Pittsburgh
AP
$168M
$791K 0.09%
+148,395
RLMD icon
231
Relmada Therapeutics
RLMD
$326M
$785K 0.09%
+162,552
ESQ icon
232
Esquire Financial Holdings
ESQ
$850M
$784K 0.09%
7,683
-3,724
TCBX icon
233
Third Coast Bancshares
TCBX
$636M
$766K 0.09%
20,158
-5,628
FOSL icon
234
Fossil Group
FOSL
$228M
$755K 0.08%
200,894
MNPR icon
235
Monopar Therapeutics
MNPR
$385M
$743K 0.08%
11,373
-3,256
DSGN icon
236
Design Therapeutics
DSGN
$572M
$741K 0.08%
+78,949
LCTX icon
237
Lineage Cell Therapeutics
LCTX
$426M
$739K 0.08%
442,221
DMAC icon
238
DiaMedica Therapeutics
DMAC
$402M
$728K 0.08%
+91,425
IZEA icon
239
IZEA Worldwide
IZEA
$66.4M
$728K 0.08%
166,138
CXDO icon
240
Crexendo
CXDO
$217M
$717K 0.08%
+110,852
FULC icon
241
Fulcrum Therapeutics
FULC
$544M
$697K 0.08%
+61,620
DERM icon
242
Journey Medical
DERM
$258M
$689K 0.08%
89,389
CODA icon
243
Coda Octopus Group
CODA
$162M
$686K 0.08%
+73,722
TOI icon
244
The Oncology Institute
TOI
$274M
$650K 0.07%
182,509
ENTA icon
245
Enanta Pharmaceuticals
ENTA
$393M
$646K 0.07%
+40,952
AMLX icon
246
Amylyx Pharmaceuticals
AMLX
$1.52B
$643K 0.07%
53,256
-21,855
IMMX icon
247
Immix Biopharma
IMMX
$492M
$632K 0.07%
+120,856
XERS icon
248
Xeris Biopharma Holdings
XERS
$964M
$629K 0.07%
80,154
-522,947
PPIH icon
249
Perma-Pipe International
PPIH
$231M
$620K 0.07%
20,421
KFS icon
250
Kingsway Financial Services
KFS
$329M
$580K 0.06%
43,088
-20,730
8 9
10
11 12